United States · FDA National Drug Code directory
Cyclobenzaprine hydrochloride
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 68788-8637_085f15c8-a837-46e6-b587-c2e138e679c5
- Product NDC
- 68788-8637
- Form
- TABLET, FILM COATED
- Composition / generic term
- Cyclobenzaprine hydrochloride
- Labeler
- Preferred Pharmaceuticals Inc.
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20240419
- Source listing expiry
- 20271231
Source-listed ingredients
- CYCLOBENZAPRINE HYDROCHLORIDE — 10 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 20 TABLET, FILM COATED in 1 BOTTLE (68788-8637-2) · 68788-8637-2
- 30 TABLET, FILM COATED in 1 BOTTLE (68788-8637-3) · 68788-8637-3
- 15 TABLET, FILM COATED in 1 BOTTLE (68788-8637-5) · 68788-8637-5
- 60 TABLET, FILM COATED in 1 BOTTLE (68788-8637-6) · 68788-8637-6
- 90 TABLET, FILM COATED in 1 BOTTLE (68788-8637-9) · 68788-8637-9
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →